Clinical Trial Update: IL-2 Plus Abatacept in FTD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at The Methodist Hospital Research Institute is evaluating the combination of interleukin-2 and abatacept for frontotemporal dementia, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• ORENCIA (ABATACEPT)
• Proleukin (aldesleukin)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Frontotemporal Degeneration | Phase 1 | Status: RECRUITING